Ovid Therapeutics Inc.
OVID | NASDAQ
$2.83
+$0.12 (+4.43%)
Sep 22, 2026, 2:22 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -15.01M | -16.99M | 9.66M | -12.16M | -4.68M | -10.24M | -9.25M | -14.01M | 8.52M | -11.69M | -15.32M | -11.25M | -12.41M | -13.36M | -11.5M | -11.97M | -14.59M | -16.11M | -25.15M | -11.38M | -15.79M | 168.57M |
Depreciation & Amortization | 16K | 35K | 17K | 17K | 99K | 141K | 147K | 169K | 148K | 136K | 401.39K | 402.46K | 394.77K | 397.96K | 439.95K | 415.36K | 452.48K | 73.81K | 56.87K | 52.18K | 53.22K | 74.74K |
Stock-Based Compensation | 1.43M | n/a | 1.2M | n/a | 1.22M | 1.28M | n/a | 1.31M | n/a | 1.97M | 1.79M | 1.63M | n/a | n/a | 1.73M | n/a | 1.72M | 1.32M | n/a | 1.16M | 1.26M | n/a |
Other Working Capital | -619K | -1.29M | -112K | 549K | -3.25M | -61K | -1.33M | 265K | 3.06M | -1.63M | 1.17M | 2.58M | -2.96M | -148.58K | -985.99K | 1.22M | -3.84M | 557.43K | 1.34M | -2.94M | -3.72M | -13.34M |
Other Non-Cash Items | -1.91M | 722K | -21.42M | 960K | -164K | -167K | -49K | -733K | -27.11M | -5.36M | -2.33M | -1.21M | 1.34M | 1.12M | 225.64K | 1.24M | 612.17K | -1.06M | 7.77M | n/a | n/a | 8.76M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -105.41K | 346.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.13M | 2.33M | 134K | -1.69M | -1.24M | -1.3M | -853K | -1.75M | 4.19M | -1.74M | 3.65M | 28.98K | -1.03M | -270K | -66.15K | -2.37M | -1.49M | -4.31M | 5.33M | -701.86K | -4.94M | -16.5M |
Operating Cash Flow | -17.59M | -13.9M | -10.41M | -12.87M | -4.77M | -10.28M | -10.01M | -15.01M | -14.26M | -16.69M | -11.91M | -10.05M | -11.71M | -12.11M | -9.18M | -12.68M | -13.29M | -20.09M | -12M | -10.87M | -19.42M | 160.9M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -22K | 4K | -34K | -19K | -1.22K | -5.25K | -7.8K | -13.56K | -63K | -18.6K | -1.26M | -45.93K | -161.96K | -15.94K | -1 | -11.51K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 48.5M | 4.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -48.1K | n/a | n/a |
Purchase of Investments | -102.74M | -4.05M | -77.06M | -4.95M | -4.95M | -4.9M | -16.71M | -9.71M | -37.03M | -9.79M | -58.51M | -29.35M | -24.82M | -9.76M | -64.11M | -31.94M | -79.42M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 16M | 10M | 5M | 10M | 17M | 10M | 38M | 10M | 50M | 30M | 10M | 25M | 45M | 40M | 60M | 30M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | -116K | n/a | -48.5M | -4.35M | n/a | n/a | 56.94K | n/a | -221.11K | -1M | n/a | 6.12K | -1.6M | n/a |
Investing Cash Flow | -86.74M | 5.95M | -72.06M | 5.05M | 12.05M | 5.1M | 21.29M | 292K | 12.82M | 20.19M | -48.52M | -4.36M | 20.07M | 30.23M | -4.17M | -1.96M | -80.68M | -1.08M | -161.96K | -64.03K | -1.58M | -11.51K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -21.31K | 549.05K | 116.19K | -21.31K |
Financial Cash Flow | 21.6M | 88.98M | 75.18M | 15K | n/a | 13K | n/a | 38K | 356K | 228K | 30.03M | 223.72K | 211.1K | 66.99K | -43.6K | 81.63K | 109.55K | 33.08K | 109.18K | 549.05K | 116.19K | 129.66K |
Net Cash Flow | -82.74M | 80.91M | -7.46M | -7.8M | 7.28M | -5.17M | 11.28M | -14.68M | -1.08M | 3.73M | -30.4M | -14.19M | 8.57M | 18.18M | -13.39M | -14.55M | -93.86M | -21.13M | -13.98M | -10.39M | -20.88M | 161.02M |
Free Cash Flow | -17.59M | -13.9M | -10.41M | -12.87M | -4.77M | -10.28M | -10.03M | -15M | -14.29M | -16.71M | -11.91M | -10.06M | -11.71M | -12.13M | -9.24M | -12.69M | -14.55M | -20.13M | -12.16M | -10.89M | -19.42M | 160.89M |
Adj. Free Cash Flow | -19.03M | -13.9M | -11.6M | -12.87M | -5.99M | -11.56M | -10.03M | -16.31M | -14.29M | -18.67M | -13.7M | -11.69M | -11.71M | -12.13M | -10.97M | -12.69M | -16.27M | -21.46M | -12.16M | -12.05M | -20.67M | 160.89M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -22K | 8K | -15.29K | -2.68K | n/a | n/a | n/a | -13.56K | -59.53K | -17.77K | -1.26M | -45.93K | -161.96K | -15.94K | -1 | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -18.71K | -16.32K | -1.22K | -5.25K | -7.8K | n/a | -3.47K | -832 | n/a | n/a | n/a | n/a | n/a | -11.51K |
Owner Earnings | -17.59M | -13.9M | -10.41M | -12.87M | -4.77M | -10.28M | -10.03M | -15M | -14.27M | -16.69M | -11.91M | -10.05M | -11.71M | -12.13M | -9.24M | -12.69M | -14.55M | -20.13M | -12.16M | -10.89M | -19.42M | 160.9M |
Add to Watchlist
Select watchlists to add or remove OVID